First Time Loading...

Progenity Inc
NASDAQ:PROG

Watchlist Manager
Progenity Inc Logo
Progenity Inc
NASDAQ:PROG
Watchlist
Price: 0.69 USD 0.01% Market Closed
Updated: May 29, 2024

Progenity Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Progenity Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Progenity Inc
NASDAQ:PROG
Cash & Cash Equivalents
$88.4m
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Cash & Cash Equivalents
$345.1m
CAGR 3-Years
-27%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
Quest Diagnostics Inc
NYSE:DGX
Cash & Cash Equivalents
$474m
CAGR 3-Years
-27%
CAGR 5-Years
0%
CAGR 10-Years
13%
CVS Health Corp
NYSE:CVS
Cash & Cash Equivalents
$9.8B
CAGR 3-Years
21%
CAGR 5-Years
11%
CAGR 10-Years
13%
Cigna Corp
NYSE:CI
Cash & Cash Equivalents
$8.4B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
14%
Laboratory Corporation of America Holdings
NYSE:LH
Cash & Cash Equivalents
$99.3m
CAGR 3-Years
-63%
CAGR 5-Years
-22%
CAGR 10-Years
-12%

See Also

What is Progenity Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
88.4m USD

Based on the financial report for Dec 31, 2021, Progenity Inc's Cash & Cash Equivalents amounts to 88.4m USD.

What is Progenity Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
22%

Over the last year, the Cash & Cash Equivalents growth was -4%. The average annual Cash & Cash Equivalents growth rates for Progenity Inc have been 22% over the past three years .